News & Updates
Filter by Specialty:
SPOTLIGHT: Durvalumab shines in real-world trial on NSCLC
Findings from the SPOTLIGHT trial have shown the efficacy of administering durvalumab after chemoradiotherapy (CRT) in patients with unresectable stage III non-small-cell lung cancer (NSCLC).
SPOTLIGHT: Durvalumab shines in real-world trial on NSCLC
21 Apr 2022
Vitamin C of little benefit to prevent or treat COVID-19, pneumonia
A recent Mendelian randomization study has found sparse evidence supporting the association of circulating vitamin C levels with the coronavirus disease 2019 (COVID-19) or pneumonia.
Vitamin C of little benefit to prevent or treat COVID-19, pneumonia
21 Apr 2022
CVT risk higher after COVID-19 than COVID-19 mRNA vaccine
An observational study from Singapore has shown that the incidence of cerebral venous thrombosis (CVT) following SARS-CoV-2 infection is greater than that following receipt of an mRNA-based SARS-CoV-2 vaccine.
CVT risk higher after COVID-19 than COVID-19 mRNA vaccine
20 Apr 2022
US-guided corticosteroid injection relieves symptoms in hip OA
An ultrasound (US)-guided intra-articular hip injection of corticosteroid and local anaesthetic, administered with advice and education, results in a rapid and sustained symptom response for individuals with hip osteoarthritis (OA), a study has shown.
US-guided corticosteroid injection relieves symptoms in hip OA
20 Apr 2022
Atrial fibrillation ups risk of death, stroke, heart failure in patients with peripheral arterial disease
Atrial fibrillation (AF) predicts mortality, stroke, and heart failure in patients with peripheral arterial disease (PAD), reveals a recent study.